Published January 30, 2026 | Version v1
Publication Open

Supplemental Files of article: Drug repurposing in cancer and Cushing's disease: halogenated salicylanilides inhibit USP8 catalytic activity and ACTH release by pituitary cells

  • 1. ROR icon CEA Grenoble

Description

Supplemental Files related to 

Thierry Waltrich-Augusto, Magda Mortier and Caroline Barette et al. Drug Repurposing in Cancer and Cushing’s Disease: Halogenated Salicylanilides Inhibit USP8 Catalytic Activity and ACTH Release by Pituitary Cells. DrugRepo. 2026. Vol. 2(2). DOI: 10.58647/DRUGREPO.25.1.0007

Authors: Thierry WALTRICH-AUGUSTO (1,2), Magda MORTIER (1), Caroline BARETTE (1), Emmanuelle SOLEILHAC (1), Laurence AUBRY (3) and Marie-Odile FAUVARQUE (1) *

(1) Univ. Grenoble Alpes, CEA, Inserm, IRIG, BGE UA13, F-38000 Grenoble, France)

(2) Present address: Wessex Investigational Sciences Hub, University of Southampton, Southampton UK-SO16 6YD

(3) Univ. Grenoble Alpes, CNRS, CEA, Inserm, IRIG, BGE UA13, F-38000 Grenoble, France

* Author for correspondence

 

Files

Waltrich-Augusto_et_al-DrugRe_Suppl Fig1.tif

Files (104.6 MB)

Name Size Download all
md5:3a378a5d114cb882468b636e91cc1a2e
37.5 kB Download
md5:a1f6db798713b5cc5030e80b08c73a5c
104.5 MB Preview Download
md5:133658f658a7d9c218c5e7568ecda004
107.1 kB Download

Additional details

Related works

Is referenced by
Publication: 10.58647/DRUGREPO.25.1.0007 (DOI)